A SCOTTISH firm has made a global breakthrough in heart surgery.

Glasgow-based CardioPrecision demonstrated a new robot-assisted surgery method in Chicago, replacing the aortic valve of the heart in several cadavers.

The company's new technology allows the procedure to be carried out through a small incision in the side of the neck, much less invasive than the traditional open-heart surgery it requires.

READ MORE: Surgeon who worked in Gaza urges support for National's MAP emergency appeal

CardioPrecision, which was spun off from NHS Scotland via commercialisation partner InnoScot Health, works to make heart surgery less invasive.

The technology was recently used in 2023, when an American hospital used it to extract a leg vein for use in a coronary artery bypass.

The Chicago demonstration is hoped to improve its business in the United States, where it is hoping to expand.

The firm calls the technology it used for the demonstration AVATAR, or Advanced Videoscopic Aortic valve surgery by Transcervical Approach using Robot-assistance.

Professor Rowan Parks, president of Royal College of Surgeons in Edinburgh said: “Robotic cardiac surgery is much less invasive than open-heart surgery. It removes the necessity of the surgeon having to cut through the breastbone to open the chest, in turn removing many access-related complications. 

“There is clearly vast potential here and it is exciting to see a Glasgow company helping to lead the way while putting Scotland firmly on the map for this pioneering approach."

Dr Ying Sutherland, chief executive of CardioPrecision, said: “The main benefit of performing surgery via the transcervical approach – making a small incision in the neck – is that this is a very well circulated area that heals quickly with little or no pain. Most operations done through the neck are performed as day cases.  

“Our CoreVista robot enabling platform therefore opens up the groundbreaking possibility of day case aortic valve surgery – a massive step forward in the field. We are tremendously grateful to have support from leading cardiothoracic surgeons in both Scotland and the USA.”